Portal de investigación
Estudio comparativo in vitro de Ceftriaxona-Sulbactam-EDTA y antibióticos comparadores contra bacilos Gram negativos productores de β-lactamasas
Datos básicos
- Código:
- UEB-ID-2021-638
- Dotación:
- Año incial:
- 2022
- Año final:
- 2024
Objetivos del proyecto
Determinar el perfil de susceptibilidad de bacilos Gram negativos productores de ß-lactamasas, incluyendo MBL frente a la combinación de Ceftriaxona/sulbactam/EDTA y antibióticos comparadores.
Documentos
- No hay documentos
Participantes
Unidades de investigación
Outputs del proyecto
Actualización sobre la resistencia antimicrobiana en instituciones de salud de nivel III y IV en Colombia entre enero del 2018 y diciembre del 2021.
De La Cadena E; (...); Villegas MV
Article. 10.7705/biomedica.7065. 2023
Antimicrobial Stewardship Programs in Latin America and the Caribbean: A Story of Perseverance, Challenges, and Goals
Restrepo-Arbeláez N; (...); Villegas MV
Review. 10.3390/antibiotics12081342. 2023
Antimicrobial stewardship programs in seven Latin American countries: facing the challenges
Pallares CJ; (...); Villegas MV
Article. 10.1186/s12879-023-08398-3. 2023
Association of COVID-19 coinfection with increased mortality among patients with Pseudomonas aeruginosa bloodstream infection in the Veterans Health Administration system
Hojat LS; (...); Epstein LH
Article. 10.1017/ash.2023.455. 2023
Burnout as a social pathology in nursing professionals: an analysis based on the theory of recognition;
Article. 10.47626/1679-4435-2022-771. 2022
Clinical data from studies involving novel antibiotics to treat multidrug-resistant Gram-negative bacterial infections
Kanj SS; (...); van Duin D
Review. 10.1016/j.ijantimicag.2022.106633. 2022
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter Baumannii Among Patients From Different Global Regions
Wang, MG; (...); Doi, YH
Article. 10.1093/cid/ciad556. 2023
Comparative In Vitro Activity of Ceftolozane/Tazobactam against Clinical Isolates of Pseudomonas aeruginosa and Enterobacterales from Five Latin American Countries
García-Betancur JC; (...); Villegas MV
Article. 10.3390/antibiotics11081101. 2022
Consenso de expertos para el tratamiento antimicrobiano de las infecciones causadas por bacilos gram negativos multirresistentes en pacientes adultos
Álvarez-Moreno C.A.; (...); Rojas S.Y.S.
Article. 10.22354/24223794.1130. 2023
Early appropriate diagnostics and treatment of MDR Gram-negative infections
Bassetti M; (...); Yu Y
Review. 10.1093/jacamr/dlac089. 2022
Gaps and barriers in the implementation and functioning of antimicrobial stewardship programmes: results from an educational and behavioural mixed methods needs assessment in France, the United States, Mexico and India (vol 4, pg dlac094, 2022)
Lazure, P; (...); Peloquin, S
Correction. 10.1093/jacamr/dlad010. 2022
Gaps and barriers in the implementation and functioning of antimicrobial stewardship programmes: results from an educational and behavioural mixed-methods needs assessment in France, the United States, Mexico and India - authors' response
Lazure P; (...); Peloquin S
Letter. 10.1093/jacamr/dlad082. 2023
Global resilience and new strategies needed for antimicrobial stewardship during the COVID-19 pandemic and beyond
Goff D.A.; (...); Sanchez P.J.
Article. 10.1002/jac5.1622. 2022
Identification of mcr-1 Genes and Characterization of Resistance Mechanisms to Colistin in Escherichia coli Isolates from Colombian Hospitals
De La Cadena E; (...); Villegas MV
Article. 10.3390/antibiotics12030488. 2023
Impact of antimicrobial stewardship programs on antibiotic consumption and antimicrobial resistance in four Colombian healthcare institutions
Pallares C; (...); Villegas MV
Article. 10.1186/s12879-022-07410-6. 2022
Molecular Mechanisms of Resistance to Ceftazidime/Avibactam in Clinical Isolates of Enterobacterales and Pseudomonas aeruginosa in Latin American Hospitals
Mojica MF; (...); Villegas MV
Article. 10.1128/msphere.00651-22. 2023
Rapid Diagnostic Test Value and Implementation in Antimicrobial Stewardship Across Low-to-Middle and High-Income Countries: A Mixed-Methods Review
Moore LSP; (...); Apisarnthanarak A
Note. 10.1007/s40121-023-00815-z. 2023
Campos de estudio
Citar el proyecto
Estudio comparativo in vitro de Ceftriaxona-Sulbactam-EDTA y antibióticos comparadores contra bacilos Gram negativos productores de β-lactamasas. (UEB-ID-2021-638). 2022-2024. IP:MARIA VIRGINIA VILLEGAS BOTERO.